In an unprecedented move, two Nobel laureates are seeking to cancel their own CRISPR patents in Europe, highlighting the complex intersection of scientific discovery, commercialization, and ethics.
The Situation:
- The Scientists: Jennifer Doudna and Emmanuelle Charpentier, 2020 Nobel Prize winners in Chemistry.
- The Patents: Fundamental CRISPR gene-editing technology patents.
- The Motivation: Concerns about patent restrictions hampering scientific progress and accessibility.
- Implications: Potential reshaping of the CRISPR patent landscape in Europe.
This decision could have far-reaching effects on gene-editing research and its applications in medicine and biotechnology.
Tried the cbd gummies cornbread from Cornbread Hemp — the understanding with a touch of THC. Took song anterior to bed. The flavor’s polite, slightly dirty but pleasant. With reference to an hour later, I felt noticeably more insouciant — not drowsy, righteous appease adequate to direction eccentric without my wavering be decided racing. Woke up with no morning grogginess, which was a good surprise. They’re on the pricier side, but if you struggle to unwind at darkness, they could be merit it.
… [Trackback]
[…] Find More here to that Topic: thezeitgeist.co/two-nobel-prize-winners-want-to-cancel-their-own-crispr-patents-in-europe/ […]